Filing Details
- Accession Number:
- 0001415889-24-022856
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-04 20:52:41
- Reporting Period:
- 2024-09-01
- Accepted Time:
- 2024-09-04 20:52:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1730430 | Kiniksa Pharmaceuticals International Plc | KNSA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1741533 | F. John Paolini | 23 Old Bond Street, Third Floor London X0 W1S 4PZ | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Share | Acquisiton | 2024-09-01 | 4,121 | $0.00 | 53,142 | No | 4 | M | Direct | |
| Class A Ordinary Share | Disposition | 2024-09-01 | 1,994 | $26.74 | 51,148 | No | 4 | F | Direct | |
| Class A Ordinary Share | Acquisiton | 2024-09-02 | 1,725 | $0.00 | 52,873 | No | 4 | M | Direct | |
| Class A Ordinary Share | Disposition | 2024-09-02 | 835 | $26.74 | 52,038 | No | 4 | F | Direct | |
| Class A Ordinary Share | Acquisiton | 2024-09-03 | 60,217 | $1.86 | 112,255 | No | 4 | M | Direct | |
| Class A Ordinary Share | Acquisiton | 2024-09-03 | 475 | $3.80 | 112,730 | No | 4 | M | Direct | |
| Class A Ordinary Share | Disposition | 2024-09-03 | 59,214 | $26.09 | 53,516 | No | 4 | S | Direct | |
| Class A Ordinary Share | Disposition | 2024-09-03 | 1,478 | $27.13 | 52,038 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Ordinary Share | Restricted Share Unit | Acquisiton | 2024-09-01 | 7,000 | $0.00 | 7,000 | $0.00 |
| Class A Ordinary Share | Share Option | Acquisiton | 2024-09-01 | 36,350 | $0.00 | 36,350 | $26.74 |
| Class A Ordinary Share | Restricted Share Unit | Disposition | 2024-09-01 | 2,497 | $0.00 | 2,497 | $0.00 |
| Class A Ordinary Share | Restricted Share Unit | Disposition | 2024-09-01 | 1,624 | $0.00 | 1,624 | $0.00 |
| Class A Ordinary Share | Restricted Share Unit | Disposition | 2024-09-02 | 1,725 | $0.00 | 1,725 | $0.00 |
| Class A Ordinary Share | Share Option | Disposition | 2024-09-03 | 60,217 | $0.00 | 60,217 | $1.86 |
| Class A Ordinary Share | Share Option | Disposition | 2024-09-03 | 475 | $0.00 | 475 | $3.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,000 | No | 4 | A | Direct | ||
| 36,350 | 2034-08-31 | No | 4 | A | Direct | |
| 4,995 | No | 4 | M | Direct | ||
| 4,872 | No | 4 | M | Direct | ||
| 1,725 | No | 4 | M | Direct | ||
| 0 | 2026-09-13 | No | 4 | M | Direct | |
| 44,549 | 2027-06-28 | No | 4 | M | Direct |
Footnotes
- Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
- This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 16, 2024.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $25.88 to $26.82. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $26.995 to $27.18. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full informationregarding the number of Shares sold at each price.
- The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024.
- The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2024.
- The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.
- The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023.
- The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the vesting commencement date September 2, 2021.
- The option is fully vested and exercisable.
Billionaire Hedge Funds
